Andrew Guggenhime - 09 Mar 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: PRESIDENT AND CFO
Signature: Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol: PCVX
Transactions as of: 09 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 11 Mar 2026, 17:24:25 UTC
Previous filing: 02 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GUGGENHIME ANDREW	PRESIDENT AND CFO	C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS	Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact	11 Mar 2026	0001230724

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Tax liability		-1,021	-0.97%	$59.32^*	104,395	09 Mar 2026	Direct	F1
holding	PCVX	Common Stock						61,850	09 Mar 2026	See Footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person.
F2	Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the annuitant and the trustee.